Mayapill 0.03 mg+0.15 mg+75 mg (Tablet)
(21 white+7 brown) tablet: ৳ 23.52
Medicine Details
Category | Details |
---|---|
Generic | Ethinyl estradiol levonorgestrel ferrous fumarate |
Company | Acme laboratories ltd |
Indications
- Inhibit Ovulation
- Inhibit sperm to enter into the uterus
- Inhibit fertilized egg to accept by uterus
- Reduce movement of sperm
- Suitable for women aged between 15-69 years
- Effective temporary contraceptive method
- Treatment for anemia due to excessive blood loss
- Regularize irregular menstruation cycle
Composition
- Ethinylestradiol USP 0.03 mg
- Levonorgestrel USP 0.15 mg
- Ferrous Fumarate BP 75 mg
Pharmacology
- Contains Levonorgestrel and Ethinyl Estradiol
- 28 tablets in a strip (21 hormone, 7 iron)
- Suppresses ovulation
- Changes in cervical mucus inhibiting sperm penetration
- Endometrial changes reducing likelihood of implantation
Dosage & Administration
- Start from first day of menstruation
- Take one tablet daily at the same time
- Take white tablet for 3 weeks, brown tablet for 7 days
- Start dose with white tablet, then brown tablet
- Use condom for 7 days if starting after menstruation
Interaction
- Enzyme inducers may decrease effectiveness
- Avoid caffeine and dairy foods while taking the drug
Contraindications
- Known hypersensitivity to any components
Side Effects
- Common: Headache, nausea, mood changes, vaginal infections
- Irregular vaginal bleeding, pain, discomfort
- Rare: liver tumors, jaundice, high blood pressure, gallbladder problem
Pregnancy & Lactation
- Contraindicated in pregnancy
- Discontinue if pregnancy occurs
- Can reduce milk production in breastfeeding females
Precautions & Warnings
- Thrombotic disorder and vascular problems
- Discontinue in case of jaundice or hypertension
- Monitor prediabetic and diabetic women
- Evaluate significant change in headaches
- Evaluate irregular bleeding or amenorrhea
Use in Special Populations
- Safety and efficacy established in women of reproductive age
- Efficacy expected to be the same in post-pubertal adolescents
- Not indicated for use before menarche
Overdose Effects
- No reports of serious illness effects from overdose
- May cause withdrawal bleeding and nausea
Therapeutic Class
- Oral Contraceptive preparations
Storage Conditions
- Store below 30°C, protected from light & moisture
Related Brands
- Femipil 0.03 mg+0.15 mg+75 mg (Tablet) - beximco-pharmaceuticals-ltd
- Noret 28 0.03 mg+0.15 mg+75 mg (Tablet) - jenphar-bangladesh-ltd
- Norgest 0.03 mg+0.15 mg+75 mg (Tablet) - techno-drugs-ltd
- Nordette 28 0.03 mg+0.15 mg+75 mg (Tablet) - social-marketing-company
- Nordette 28 0.03 mg+0.15 mg+75 mg (Tablet) - pfizer